Deutsche Bank’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.79M | Buy |
57,260
+49,013
| +594% | +$2.38M | ﹤0.01% | 1511 |
|
|
2025
Q1 | $281K | Buy |
8,247
+114
| +1% | +$3.88K | ﹤0.01% | 2766 |
|
|
2024
Q4 | $320K | Buy |
8,133
+3,205
| +65% | +$126K | ﹤0.01% | 2842 |
|
|
2024
Q3 | $232K | Buy |
4,928
+114
| +2% | +$5.36K | ﹤0.01% | 2810 |
|
|
2024
Q2 | $260K | Sell |
4,814
-379
| -7% | -$20.5K | ﹤0.01% | 2631 |
|
|
2024
Q1 | $354K | Buy |
5,193
+136
| +3% | +$9.27K | ﹤0.01% | 2476 |
|
|
2023
Q4 | $317K | Buy |
5,057
+423
| +9% | +$26.5K | ﹤0.01% | 2576 |
|
|
2023
Q3 | $210K | Buy |
4,634
+2
| +0% | +$91 | ﹤0.01% | 2720 |
|
|
2023
Q2 | $260K | Sell |
4,632
-3,759
| -45% | -$211K | ﹤0.01% | 2730 |
|
|
2023
Q1 | $380K | Buy |
8,391
+3,724
| +80% | +$168K | ﹤0.01% | 2646 |
|
|
2022
Q4 | $190K | Buy |
4,667
+3,924
| +528% | +$160K | ﹤0.01% | 2994 |
|
|
2022
Q3 | $49K | Sell |
743
-123,149
| -99% | -$8.12M | ﹤0.01% | 3558 |
|
|
2022
Q2 | $7.53M | Sell |
123,892
-198
| -0.2% | -$12K | ﹤0.01% | 1113 |
|
|
2022
Q1 | $7.79M | Buy |
124,090
+121,485
| +4,664% | +$7.63M | ﹤0.01% | 1198 |
|
|
2021
Q4 | $197K | Sell |
2,605
-349
| -12% | -$26.4K | ﹤0.01% | 3359 |
|
|
2021
Q3 | $331K | Sell |
2,954
-1,263
| -30% | -$142K | ﹤0.01% | 3272 |
|
|
2021
Q2 | $683K | Sell |
4,217
-74,365
| -95% | -$12M | ﹤0.01% | 3009 |
|
|
2021
Q1 | $9.58M | Sell |
78,582
-82,684
| -51% | -$10.1M | 0.01% | 1214 |
|
|
2020
Q4 | $24.7M | Buy |
161,266
+107,681
| +201% | +$16.5M | 0.02% | 728 |
|
|
2020
Q3 | $4.48M | Sell |
53,585
-5,518
| -9% | -$462K | ﹤0.01% | 1304 |
|
|
2020
Q2 | $4.34M | Buy |
59,103
+56,046
| +1,833% | +$4.12M | ﹤0.01% | 1374 |
|
|
2020
Q1 | $130K | Sell |
3,057
-131,083
| -98% | -$5.57M | ﹤0.01% | 3100 |
|
|
2019
Q4 | $8.17M | Buy |
134,140
+97,244
| +264% | +$5.92M | 0.01% | 1191 |
|
|
2019
Q3 | $1.51M | Buy |
36,896
+36,420
| +7,651% | +$1.49M | ﹤0.01% | 2068 |
|
|
2019
Q2 | $21K | Buy |
476
+9
| +2% | +$397 | ﹤0.01% | 4475 |
|
|
2019
Q1 | $16K | Sell |
467
-4,818
| -91% | -$165K | ﹤0.01% | 4515 |
|
|
2018
Q4 | $150K | Sell |
5,285
-1,547
| -23% | -$43.9K | ﹤0.01% | 3911 |
|
|
2018
Q3 | $303K | Sell |
6,832
-155,561
| -96% | -$6.9M | ﹤0.01% | 3967 |
|
|
2018
Q2 | $9.54M | Buy |
162,393
+137,958
| +565% | +$8.11M | ﹤0.01% | 1790 |
|
|
2018
Q1 | $1.12M | Sell |
24,435
-33,830
| -58% | -$1.54M | ﹤0.01% | 3206 |
|
|
2017
Q4 | $1.37M | Buy |
58,265
+29,881
| +105% | +$701K | ﹤0.01% | 2956 |
|
|
2017
Q3 | $506K | Buy |
28,384
+27,884
| +5,577% | +$497K | ﹤0.01% | 3343 |
|
|
2017
Q2 | $8K | Sell |
500
-6,400
| -93% | -$102K | ﹤0.01% | 4286 |
|
|
2017
Q1 | $150K | Buy |
+6,900
| New | +$150K | ﹤0.01% | 3570 |
|